Following a release from Progen (PGL) around the signing of a non-binding letter of intent with Medigen Copr. Progen Pharmaceuticals the stock is in a trading halt. Normal trading of PGL is expected to retrun on Friday, 2 July 2010 or when the announcement is released to the market.

Comments


Terms & Rules

As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use

Before using this Biomedical Investing website

OR